Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL991018

CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.O=S(=O)([O-])OS(=O)(=O)O[O-]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.44
RECQL P46063 2/20 0.40
TSHR P16473 2/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
EPHX2 P34913 1/20 0.40
BLM P54132 1/20 0.40
SLC22A2 O15244 1/20 0.39
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HIF1A Q16665 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DNM1 Q05193 4/20 0.34
FUT7 Q11130 1/20 0.32
CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6616480 0.95 SLC22A1 (0.46) SLC22A1RECQLTSHRGLAHPGD
Tetrahexylammonium SCHEMBL7662219 0.95 SLC22A1 (0.46) SLC22A1RECQLTSHRGLAHPGD
SCHEMBL6617792 0.90 DNM1 (0.52) SLC22A1RECQLTSHRGLAHPGD
Tetrapropylammonium SCHEMBL6620844 0.89 SLC22A1 (0.40) SLC22A1RECQLTSHRGLAHPGD
Tetrabuthylammonium SCHEMBL1259012 0.86 SLC22A1 (0.55) SLC22A1RECQLTSHRGLAHPGD
Tetrabuthylammonium SCHEMBL10840728 0.86 SLC22A1 (0.55) SLC22A1RECQLTSHRGLAHPGD
SCHEMBL6618755 0.84 DNM1 (0.50) RECQLTSHRGLAHPGDMAPK1
Tetrabuthylammonium SCHEMBL28818846 0.84 SLC22A1 (0.52) SLC22A1RECQLTSHRGLAHPGD
Tetrylammonium SCHEMBL1507332 0.82 TSHR (0.36) TSHR
SCHEMBL6619584 0.81 CYP1A2 (0.40) HPGDMAPK1ALDH1A1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178223-A Preparation method of Belzutifan and intermediate thereof 上海皓鸿生物医药科技有限公司 2023-05-30 CN claimed
US-20090310285-A1 PROCESS FOR PREPARING POLYTHIOPHENES H.C. STARCK GMBH (DE) 2009-12-17 US claimed
EP-2079795-A1 PARTICLE-MATRIX COMPOSITION COATED WITH MIXTURE COMPRISING POLYSULFIDE POLYMER Teijin Aramid B.V. (NL) 2009-07-22 EP claimed
US-20080319097-A1 Polyether Polymer Matrix VERSAMATRIX A/S (DK) 2008-12-25 US claimed
WO-2008098109-A9 HYDROGEL COMPOSITIONS UNIV NORTHWESTERN (US) 2008-12-11 WO claimed
US-20080196626-A1 High silicon-content resin composition used to form thin film thermosets; form low k dielectric constant materials; hard mask and underlayer materials with anti-reflective properties for photolithography industry MERCK PATENT GMBH (DE) 2008-08-21 US claimed
WO-2008098109-A2 HYDROGEL COMPOSITIONS NORTHWESTERN UNIVERSITY (US) 2008-08-14 WO claimed
WO-2008040508-A1 PARTICLE-MATRIX COMPOSITION COATED WITH MIXTURE COMPRISING POLYSULFIDE POLYMER TEIJIN ARAMID B.V. (NL) 2008-04-10 WO claimed
EP-1784441-A1 A HIGH LOADING FUNCTIONAL RESIN VersaMatrix A/S (DK) 2007-05-16 EP claimed
WO-2006021217-A1 A HIGH LOADING FUNCTIONAL RESIN VERSAMATRIX A/S (DK) 2006-03-02 WO claimed
US-20260049309-A1 REGULATION OF ACTIVITY OF RNAI MOLECULES NOVO NORDISK AS (DE) 2026-02-19 US disclosed
US-12508343-B2 Solid forms for tissue repair CARTIHEAL (2009) LTD. (IL) 2025-12-30 US disclosed
US-20250197439-A1 DECARBOXYLATIVE ACETOXYLATION USING MN(II) OR MN(III) REAGENT FOR SYNTHESIS OF 4'-ACETOXY-NUCLEOSIDE AND USE THEREOF FOR SYNTHESIS OF CORRESPONDING 4'-(DIMETHOXYPHOSPHORYL)METHOXY-NUCLEOTIDE DICERNA PHARMACEUTICALS, INC. (US) 2025-06-19 US disclosed
US-20250122500-A1 RNAi OLIGONUCLEOTIDE CONJUGATES NOVO NORDISK A/S (DK) 2025-04-17 US disclosed
WO-2025054459-A1 RNAI OLIGONUCLEOTIDE CONJUGATES DICERNA PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed
WO-2002081447-A1 3-CYCLOPENTYLOXY-4-METHOXYPHENYL-ISOTHIAZOLINONE DERIVATIVES AND THE USE THEREOF DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2002-10-17 WO disclosed
US-6130338-A OXIDATING THE CORRESPONDING 3-PYRROLINE COMPOUND TO GIVE AN EPOXYPYRROLIDINE COMPOUND TORAY INDUSTRIES, INC. (JP) 2000-10-10 US disclosed
EP-0985664-A2 Method of producing pyrrolidine derivatives TORAY INDUSTRIES, INC. (JP) 2000-03-15 EP disclosed
EP-0781286-A1 7,7-DISUBSTITUTED CEPHEM-4-KETONES PHARMACIA & UPJOHN S.p.A. (IT) 1997-07-02 EP disclosed
US-5202004-A Determining contour of surface DIGITAL INSTRUMENTS, INC. (US) 1993-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197439-A1 DECARBOXYLATIVE ACETOXYLATION USING MN(II) OR MN(III) REAGENT FOR SYNTHESIS OF 4'-ACETOXY-NUCLEOSIDE AND USE THEREOF FOR SYNTHESIS OF CORRESPONDING 4'-(DIMETHOXYPHOSPHORYL)METHOXY-NUCLEOTIDE ME3, POLRMT, NSUN3 SLC22A1 2956/4885RECQL 1421/4885TSHR 2798/4885
US-20260049309-A1 REGULATION OF ACTIVITY OF RNAI MOLECULES FABP1, SREBF2, RNASE1 SLC22A1 1309/4885RECQL 2997/4885TSHR 1209/4885
US-12508343-B2 Solid forms for tissue repair BMP2, FGF2, COL2A1 SLC22A1 2784/4885RECQL 929/4885TSHR 3857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.